Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
390
-
Total 13F shares, excl. options
-
50.6M
-
Shares change
-
-247K
-
Total reported value, excl. options
-
$5.64B
-
Value change
-
-$78.6M
-
Put/Call ratio
-
0.8
-
Number of buys
-
229
-
Number of sells
-
-155
-
Price
-
$111.43
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2016
455 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q1 2016.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 390 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.6M shares
.
Largest 10 shareholders include FMR LLC (4.44M shares), SCOPIA CAPITAL MANAGEMENT LP (4.22M shares), VANGUARD GROUP INC (3.56M shares), BlackRock Fund Advisors (2.16M shares), AJO, LP (1.88M shares), STATE STREET CORP (1.85M shares), DEUTSCHE BANK AG\ (1.58M shares), BlackRock Institutional Trust Company, N.A. (1.54M shares), Palo Alto Investors, LLC (1.53M shares), and AQR CAPITAL MANAGEMENT LLC (1.31M shares).
This table shows the top 390 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.